The effects of varying doses of nocturnal sleep time on lapses of attention from the psychomotor vigilance test (PVT). Panel A from Van Dongen et al. 12 involved experimental sleep restriction of n = 36 healthy adults for 14 consecutive nights. In this experiment sleep was restricted for 14 consecutive nights. Subjects were randomized to 4 h time in bed (n = 13), 6 h time in bed (n = 13), or 8 h time in bed (n = 9). PVT performance was assessed every 2 h (9 times each day) from 07:30 to 23:30. The graph shows systematic increases in lapses of sustained attention when sleep was restricted to either 4 h (p < 0.001) or 6 h (p < 0.001) per night, but not when sleep was restricted to 8 h per night (p = 0.29). The increase in lapsing was worse in the 4-h sleep condition than in the 6-h sleep condition (p = 0.036), further supporting a dose-response relationship within and between conditions. The horizontal dotted line shows the level of lapsing found in a separate experiment when subjects had been awake continuously for 64–88 h. For example, by day 7, subjects in the 6-h sleep restriction condition averaged 54 lapses (6 lapses × 9 test times) that day, while those in the 4-h sleep condition averaged 70 lapses that day. Panel B shows comparable sleep restriction data from Belenky et al.10 In this study sleep was restricted for 7 consecutive nights in n = 66 healthy adults. They were randomized to 3 h time in bed (n = 13), 5 h time in bed (n = 13), 7 h time in bed (n = 13), or 9 h time in bed (n = 16). Performance was assessed 4 times each day from 09:00 to 21:00. PVT lapses increases steadily across days in the 3-h (p = 0.001) and 5-h (p = 0.001) sleep restriction conditions (PVT response speed, but not lapses, was reduced in the 7-h condition, not shown). As in Panel A, the horizontal dotted line shows the level of lapsing found in a separate experiment when subjects had been awake continuously for 64–88 h.12 Considering data in both Panels A and B, it is clear that restriction of nocturnal sleep time to <7 h per night in healthy adults results in systematic increases in lapses of waking attention that get progressively worse across days, in a dose-response manner.